Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms IVACFLU-A |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza in Birds | Phase 3 | VN | 07 Mar 2017 | |
Influenza, Human | Phase 3 | VN | 07 Mar 2017 | |
influenza A subtype H5N1 infection | Phase 3 | VN | 01 Jun 2014 | |
Influenza A virus infection | Phase 3 | - | - |
NCT02612909 (Pubmed) Manual | Phase 2/3 | - | 930 | bmulwxrtns(zykqiggjht) = ijrfhcyxgw wyzhkqqdqv (iibcqbpmnh ) View more | Positive | 05 Feb 2020 | |
Phase 2/3 | 930 | Placebo (Phase 2: Placebo) | njrnsehxkp(ejvsnclkcm) = nkxhsysokk vrcsihkpcv (dueudrzhwk, tgdpbhgsty - yqregukure) View more | - | 16 Apr 2019 | ||
(Phase 2: Vaccine (15 mcg)) | njrnsehxkp(ejvsnclkcm) = sbksylcztf vrcsihkpcv (dueudrzhwk, tnkpfbpmyz - ymdvjbzgdf) View more | ||||||
Phase 1 | 48 | Placebo (Placebo) | aznykklzxw(eoxzwscnaj) = fgodlxvicd zfzptsitjz (salzowdzfh, airnldylwc - yebkuzbibl) View more | - | 27 Feb 2019 | ||
(Influenza Vaccine) | aznykklzxw(eoxzwscnaj) = qytrmnipcp zfzptsitjz (salzowdzfh, iksrdfumfs - wibuquygtj) View more |